Morocco vs Panama: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Morocco
77.0%
in 2025
Panama
77.0%
in 2025
Morocco rank
124th
Panama rank
124th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Morocco
- Panama
How they compare
Morocco currently reports 77.0% against 77.0% in Panama, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Panama ahead.
Morocco ranks 124th and Panama ranks 124th of 194 countries.
Across the 3 decades both report, Morocco averaged higher in 1 and Panama in 1.
Head to head by decade
| Decade | Morocco | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 75.5% | 84.2% | 8.7% | Panama |
| 2020s | 89.3% | 80.7% | 8.7% | Morocco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Morocco or Panama?
- Morocco, at 77.0% against 77.0% in Panama as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Morocco and Panama?
- 0.0%, with Morocco ahead.
- How many years of comparable data are there for Morocco and Panama?
- 18 years are reported by both, from 2008 to 2025.
- How do Morocco and Panama rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Morocco ranks 124th and Panama ranks 124th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.